245 related articles for article (PubMed ID: 32535738)
1. MR imaging of epithelial ovarian cancer: a combined model to predict histologic subtypes.
Qian L; Ren J; Liu A; Gao Y; Hao F; Zhao L; Wu H; Niu G
Eur Radiol; 2020 Nov; 30(11):5815-5825. PubMed ID: 32535738
[TBL] [Abstract][Full Text] [Related]
2. MR-based radiomics-clinical nomogram in epithelial ovarian tumor prognosis prediction: tumor body texture analysis across various acquisition protocols.
Wang T; Wang H; Wang Y; Liu X; Ling L; Zhang G; Yang G; Zhang H
J Ovarian Res; 2022 Jan; 15(1):6. PubMed ID: 35022079
[TBL] [Abstract][Full Text] [Related]
3. MR image-based radiomics to differentiate type Ι and type ΙΙ epithelial ovarian cancers.
Jian J; Li Y; Pickhardt PJ; Xia W; He Z; Zhang R; Zhao S; Zhao X; Cai S; Zhang J; Zhang G; Jiang J; Zhang Y; Wang K; Lin G; Feng F; Wu X; Gao X; Qiang J
Eur Radiol; 2021 Jan; 31(1):403-410. PubMed ID: 32743768
[TBL] [Abstract][Full Text] [Related]
4. [Prediction of platinum-based chemotherapy sensitivity for epithelial ovarian cancer by multi-sequence MRI-based radiomic nomogram].
Mao MM; Li HM; Shi J; Qiu QS; Feng F
Zhonghua Yi Xue Za Zhi; 2022 Jan; 102(3):201-208. PubMed ID: 35042289
[No Abstract] [Full Text] [Related]
5. Multiparametric MR radiomics in brain glioma: models comparation to predict biomarker status.
He J; Ren J; Niu G; Liu A; Wu Q; Xie S; Ma X; Li B; Wang P; Shen J; Wu J; Gao Y
BMC Med Imaging; 2022 Aug; 22(1):137. PubMed ID: 35931979
[TBL] [Abstract][Full Text] [Related]
6. MRI radiomics analysis for predicting preoperative synchronous distant metastasis in patients with rectal cancer.
Liu H; Zhang C; Wang L; Luo R; Li J; Zheng H; Yin Q; Zhang Z; Duan S; Li X; Wang D
Eur Radiol; 2019 Aug; 29(8):4418-4426. PubMed ID: 30413955
[TBL] [Abstract][Full Text] [Related]
7. Nomograms of Combining MRI Multisequences Radiomics and Clinical Factors for Differentiating High-Grade From Low-Grade Serous Ovarian Carcinoma.
Li C; Wang H; Chen Y; Zhu C; Gao Y; Wang X; Dong J; Wu X
Front Oncol; 2022; 12():816982. PubMed ID: 35747838
[TBL] [Abstract][Full Text] [Related]
8. Nomogram based on ultrasound radiomics score and clinical variables for predicting histologic subtypes of epithelial ovarian cancer.
Yao F; Ding J; Lin F; Xu X; Jiang Q; Zhang L; Fu Y; Yang Y; Lan L
Br J Radiol; 2022 Aug; 95(1136):20211332. PubMed ID: 35612547
[TBL] [Abstract][Full Text] [Related]
9. [Application of MRI-based Radiomics Models in the Assessment of Hepatic Metastasis of Rectal Cancer].
Hu SX; Yang K; Wang XR; Wen DG; Xia CC; Li X; Li ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 52(2):311-318. PubMed ID: 33829708
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging radiomics in categorizing ovarian masses and predicting clinical outcome: a preliminary study.
Zhang H; Mao Y; Chen X; Wu G; Liu X; Zhang P; Bai Y; Lu P; Yao W; Wang Y; Yu J; Zhang G
Eur Radiol; 2019 Jul; 29(7):3358-3371. PubMed ID: 30963272
[TBL] [Abstract][Full Text] [Related]
11. Multiparameter MRI Radiomics Model Predicts Preoperative Peritoneal Carcinomatosis in Ovarian Cancer.
Yu XY; Ren J; Jia Y; Wu H; Niu G; Liu A; Gao Y; Hao F; Xie L
Front Oncol; 2021; 11():765652. PubMed ID: 34790579
[TBL] [Abstract][Full Text] [Related]
12. MR imaging of thymomas: a combined radiomics nomogram to predict histologic subtypes.
Xiao G; Hu YC; Ren JL; Qin P; Han JC; Qu XY; Rong WC; Yan WQ; Tian Q; Han Y; Wang WP; Wang SM; Ma J; Wang W; Cui GB
Eur Radiol; 2021 Jan; 31(1):447-457. PubMed ID: 32700020
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma.
Wang G; He L; Yuan C; Huang Y; Liu Z; Liang C
Eur J Radiol; 2018 Jan; 98():100-106. PubMed ID: 29279146
[TBL] [Abstract][Full Text] [Related]
14. Radiomics derived from dynamic contrast-enhanced MRI pharmacokinetic protocol features: the value of precision diagnosis ovarian neoplasms.
Song XL; Ren JL; Zhao D; Wang L; Ren H; Niu J
Eur Radiol; 2021 Jan; 31(1):368-378. PubMed ID: 32767049
[TBL] [Abstract][Full Text] [Related]
15. CT and MRI findings of type I and type II epithelial ovarian cancer.
Liu D; Zhang L; Indima N; Peng K; Li Q; Hua T; Tang G
Eur J Radiol; 2017 May; 90():225-233. PubMed ID: 28583639
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted imaging-based radiomics in epithelial ovarian tumors: Assessment of histologic subtype.
Xu Y; Luo HJ; Ren J; Guo LM; Niu J; Song X
Front Oncol; 2022; 12():978123. PubMed ID: 36544703
[TBL] [Abstract][Full Text] [Related]
17. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
[TBL] [Abstract][Full Text] [Related]
18. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
[TBL] [Abstract][Full Text] [Related]
19. A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients.
Leandersson P; Åkesson A; Hedenfalk I; Malander S; Borgfeldt C
PLoS One; 2020; 15(10):e0240418. PubMed ID: 33075095
[TBL] [Abstract][Full Text] [Related]
20. DCE-MRI-based radiomics in predicting angiopoietin-2 expression in hepatocellular carcinoma.
Zheng J; Du PZ; Yang C; Tao YY; Li L; Li ZM; Yang L
Abdom Radiol (NY); 2023 Nov; 48(11):3343-3352. PubMed ID: 37495746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
